< Back to Find a Trial

A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TPI-287 in Alzheimer’s Disease

ID

NCT01966666

Condition Studied

Alzheimer's Disease

Corticobasal Degeneration

Progressive Supranuclear Palsy

Phase

Phase I

Status

Closed

Intervention

TPI-287

Principal Investigator

Adam Boxer, MD, PhD

[email protected]

415 - 476 - 0668

Please go to ClinicalTrials.gov for more information.